EQUITYRX

Serial Number 78974204
Registration 3365964
710

Registration Progress

Application Filed
Sep 14, 2006
Under Examination
Approved for Publication
Oct 3, 2007
Published for Opposition
Oct 23, 2007
Registered
Jan 8, 2008

Trademark Image

EQUITYRX

Basic Information

Serial Number
78974204
Registration Number
3365964
Filing Date
September 14, 2006
Registration Date
January 8, 2008
Published for Opposition
October 23, 2007
Cancellation Date
August 15, 2014
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Aug 15, 2014

Rights Holder

CEO International Inc.

03
Address
Suite C12, Market Place
Providencialies
TC

Ownership History

CEO International Inc.

Original Applicant
03
Providencialies TC

CEO International Inc.

Owner at Publication
03
Providencialies TC

CEO International Inc.

Original Registrant
03
Providencialies TC

Legal Representation

Attorney
John P. Shannon

USPTO Deadlines

Next Deadline
799 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2008-01-08)
Due Date
January 08, 2028
Grace Period Ends
July 08, 2028

Application History

15 events
Date Code Type Description Documents
Aug 15, 2014 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Jan 8, 2008 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 23, 2007 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 3, 2007 NPUB O NOTICE OF PUBLICATION Loading...
Sep 18, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 14, 2007 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 11, 2007 ALIE A ASSIGNED TO LIE Loading...
Sep 11, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 11, 2007 ACEC I AMENDMENT FROM APPLICANT ENTERED Loading...
Aug 2, 2007 MAIL I PAPER RECEIVED Loading...
Jan 31, 2007 CNRT F NON-FINAL ACTION MAILED Loading...
Jan 30, 2007 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 29, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 21, 2006 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Sep 20, 2006 NWAP I NEW APPLICATION ENTERED Loading...

Additional Information

Pseudo Mark
EQUITY RX